AVEO : Summary for AVEO Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets open in 4 hrs 8 mins

AVEO Pharmaceuticals, Inc. (AVEO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.77+0.01 (+1.58%)
At close: 4:00PM EST
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close0.76
Bid0.00 x
Ask1.62 x 1100
Day's Range0.75 - 0.79
52 Week Range0.54 - 1.23
Avg. Volume314,890
Market Cap85.83M
PE Ratio (TTM)-3.09
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Business Wire14 days ago

    AVEO Announces Clinical and Regulatory Updates for Tivozanib

    AVEO Oncology today announced clinical and regulatory updates for its lead drug candidate, tivozanib, an oral, once-daily, vascular endothelial growth factor tyrosine kinase inhibitor .

  • Business Wire17 days ago

    AVEO to Present at the 19th Annual BIO CEO & Investor Conference

    AVEO Oncology today announced that Michael Needle, M.D., Chief Medical Officer, will present at the 19th Annual BIO CEO & Investor Conference on Monday, February 13, 2017 at 8:30 AM E.T.

  • Capital Cube2 months ago

    ETFs with exposure to AVEO Pharmaceuticals, Inc. : December 22, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to AVEO Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to AVEO-US. Comparing the performance and risk of AVEO Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)